Inflammatory markers and risk of hip fracture in older white women: The study of osteoporotic fractures

Journal of Bone and Mineral Research

Volumn 29, Issue 9, 2014, Pages 2057-2064

  Barbour, Kamil E ^a   Lui, Li Yung ^b   Ensrud, Kristine E ^c   Hillier, Teresa A ^d   Leblanc, Erin S ^d   Ing, Steven W ^e   Hochberg, Marc C ^f   Cauley, Jane A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CASE COHORT DESIGN; CYTOKINES AND CYTOKINE SOLUBLE RECEPTORS; HIP FRACTURE; INFLAMMATORY MARKERS; OLDER WHITE WOMEN

Indexed keywords

CYSTATIN C; CYTOKINE; CYTOKINE RECEPTOR; CYTOKINE SOLUBLE RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 SOLUBLE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR SOLUBLE RECEPTOR 1; TUMOR NECROSIS FACTOR SOLUBLE RECEPTOR 2; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER;

AGED; ARTICLE; BONE DENSITY; CAUCASIAN; CONTROLLED STUDY; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; FEMUR NECK FRACTURE; FOLLOW UP; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PATHOGENESIS; RISK FACTOR; VERY ELDERLY; COHORT ANALYSIS; HIP FRACTURES; INCIDENCE; METABOLISM; OSTEOPOROTIC FRACTURES; PROPORTIONAL HAZARDS MODEL; SOLUBILITY; UNITED STATES;

AGED; AGED, 80 AND OVER; BIOMARKERS; COHORT STUDIES; CYTOKINES; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; OSTEOPOROTIC FRACTURES; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CYTOKINE; RISK FACTORS; SOLUBILITY; UNITED STATES;

EID: 84906337637     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2245     Document Type: Article

References (47)

1. Majumdar S,. Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheumatol. 2008; 35 (2): 190-2.
2. Cummings SR, Black DM, Rubin SM,. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med. 1989; 149 (11): 2445.
3. LeBlanc ES, Hillier TA, Pedula KL, et al. Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med. 2011; 171 (20): 1831-7.
4. Haentjens P, Magaziner J, Colõn-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Inter Med. 2010; 152 (6): 380-90.
5. Chung HY, Kim HJ, Kim JW, Yu BP,. The inflammation hypothesis of aging. Annals of the New York Academy of Sciences. 2001; 928 (1): 327-35.
6. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351 (25): 2599-610.
7. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE,. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004; 53 (3): 693-700.
8. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999; 106 (5): 506-12.
9. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE,. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002; 59 (3): 371-8.
10. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R,. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 1995; 136 (7): 3054-61.
11. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R,. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res. 2001; 16 (2): 328-37.
12. Mosekilde L, Beck-Nielsen H, Sorensen OH, et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women-results of the Danish Osteoporosis Prevention Study. Maturitas. 2000; 36 (3): 181-93.
13. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G,. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008; 93 (5): 1952-8.
14. Gertz ER, Silverman NE, Wise KS, et al. Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J Clin Densitom. 2010; 13 (3): 277-82.
15. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab. 2001; 86 (5): 2032-42.
16. Cauley JA, Danielson ME, Boudreau RM, et al. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007; 22 (7): 1088-95.
17. Barbour KE, Boudreau R, Danielson ME, et al. Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res. 2012; 27 (5): 1167-76.
18. Cummings SR, Black DM, Nevitt MC, et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990; 263 (5): 665-8.
19. Prentice RL,. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986; 73 (1): 1-11.
20. Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT,. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry. 1999; 56 (10): 889-95.
21. Penninx BW, Kritchevsky SB, Newman AB, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004; 52 (7): 1105-13.
22. Gregg EW, Cauley JA, Stone K, et al. Relationship of changes in physical activity and mortality among older women. JAMA: The Journal of the American Medical Association. 2003; 289 (18): 2379-86.
23. Paffenbarger RS, Wing AL, Hyde RT,. Physical activity as an index of heart attack risk in college alumni. American Journal of epidemiology. 1978; 108 (3): 161-75.
24. Ensrud KE, Palermo L, Black DM, et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. Journal of Bone and Mineral Research. 2009; 10 (11): 1778-87.
25. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults evidence for a phenotype. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2001; 56 (3): M146-M157.
26. Ensrud KE, Ewing SK, Fredman L, et al. Circulating 25-hydroxyvitamin D levels and frailty status in older women. Journal of Clinical Endocrinology & Metabolism. 2010; 95 (12): 5266-73.
27. Erlandsen E, Randers E, Kristensen J,. Evaluation of the Dade Behring N latex cystatin C assay on the Dade Behring Nephelometer II System. Scandinavian journal of clinical & laboratory investigation. 1999; 59 (1): 1-8.
28. Visser M, Simonsick EM, Colbert LH, et al. Type and intensity of activity and risk of mobility limitation: the mediating role of muscle parameters. Journal of the American Geriatrics Society. 2005; 53 (5): 762-70.
29. Fox K, Cummings S, Williams E, Stone K,. Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporosis international. 2000; 11 (12): 1018-23.
30. LaCroix AZ, Lee JS, Wu L, et al. Cystatin-C, Renal Function, and Incidence of Hip Fracture in Postmenopausal Women. Journal of the American Geriatrics Society. 2008; 56 (8): 1434-41.
31. Ensrud KE, Parimi N, Cauley JA, et al. Cystatin C and risk of hip fractures in older women. Journal of Bone and Mineral Research. 2013; 28 (6): 1275-82.
32. Fried LF, Biggs ML, Shlipak MG, et al. Association of kidney function with incident hip fracture in older adults. Journal of the American Society of Nephrology. 2007; 18 (1): 282-6.
33. Ensrud KE, Barbour K, Canales MT, et al. Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI). Osteoporos Int. 2012; 23 (3): 887-99.
34. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney international. 2008; 75 (6): 652-60.
35. Ensrud KE,. Fracture Risk in CKD. Clinical Journal of the American Society of Nephrology. 2013; 8 (8): 1282-3.
36. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC,. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009; 53 (4): 596-605.
37. Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004; 15 (12): 3184-91.
38. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G,. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005; 68 (1): 237-45.
39. Bertani T, Abbate M, Zoja C, et al. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol. 1989; 134 (2): 419-30.
40. Le Hir M, Haas C, Marino M, Ryffel B,. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest. 1998; 78 (12): 1625-31.
41. Keller C, Odden M, Fried L, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney international. 2006; 71 (3): 239-44.
42. Witko-Sarsat V, Friedlander M, Khoa TN, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure1, 2. The Journal of Immunology. 1998; 161 (5): 2524-32.
43. Kostenuik PJ, Shalhoub V,. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des. 2001; 7 (8): 613-35.
44. Cenci S, Toraldo G, Weitzmann MN, et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A. 2003; 100 (18): 10405-10.
45. Barbour KE, Houston DK, Cummings SR, et al. Calciotropic hormones and the risk of hip and nonspine fractures in older adults: the Health ABC Study. J Bone Miner Res. 2012; 27 (5): 1177-85.
46. Robinson-Cohen C, Katz R, Hoofnagle AN, et al. Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. Journal of Clinical Endocrinology & Metabolism. 2011; 96 (7): 2186-93.
47. Oei L, Campos-Obando N, Dehghan A, et al. Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: the Rotterdam Study. Osteoporosis International. 2014; 25: 1247-54.